NEU 3.50% $14.05 neuren pharmaceuticals limited

Share Price, page-9510

  1. 2,168 Posts.
    lightbulb Created with Sketch. 572
    Jimbo,

    This along with the next x 2 trial results is indeed is the big catalyst in my view, the pivotal point for Neu's future to be decided.

    At this point they in my view will know all options on the table and will be a matter of selection of their journey based on 2 other results and FDA requirements for phase 3's
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.